Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies. PIK3CA mutations in colorectal cancer

This review gives hand on recent advances of personalized oncology in several cancer disease models including leukemia, melanoma, breast cancer, lung cancer, colorectal cancer,

Dietary fiber in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study... luminal short

For a short explanation of why the committee made these recommendations and how they might affect practice, see the rationale and impact section on identifying children and young

Aims: This study carried in patients with metastatic colorectal cancer (mCRC) or head and neck cancer (HNC) aims to evaluate, in a real-life setting, the relationship

Moreover, since the treatment with the BRAFi Vemurafenib also enhances autophagy in melanoma [40,41], colorectal cancer [47] and thyroid cancer cells [46], our results further

It is thought that a defective or missing BRCA1 protein is unable to repair damaged DNA or fix mutations that occur in other genes, which is the main cause of its association

Morphofunctional and Molecular Assessment of Nutritional Status in Head and Neck Cancer Patients Undergoing Systemic Treatment: Role of Inflammasome in Clinical Nutrition..